Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01586026 · ClinicalTrials.gov registry record
Study to Extend the Maximum Maintenance Flushing Interval for Ports With Distally Valved Catheters
A clinical trial, sponsored by C. R. Bard.
- Terminated
- Registry status
- 171
- Enrollment target
NCT01586026 is a clinical trial that was terminated before completion, run by C. R. Bard. The registered enrollment target is 171 participants.
The verdict
NCT01586026 was terminated before completion, sponsored by C. R. Bard.
- TERMINATED
- Registry status
- 171 participants
- Enrollment target
Study Summary
This study is to compare the rate of adverse events in subjects with maintenance flushes greater than 28 days.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2012-04 |
| Est. Completion | 2012-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01586026
The ClinicalTrials.gov registry entry for NCT01586026 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01586026 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01586026 about?
NCT01586026 is a clinical study titled "Study to Extend the Maximum Maintenance Flushing Interval for Ports With Distally Valved Catheters". This study is to compare the rate of adverse events in subjects with maintenance flushes greater than 28 days.
What is the current status of trial NCT01586026?
This trial is currently terminated. The enrollment target is 171 participants. The study started on 2012-04. Estimated completion is 2012-11.
Who is sponsoring clinical trial NCT01586026?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.